Profusa garners over $45 mln Series C
South San Francisco-based Profusa, a developer of tissue-integrating biosensors for continuous monitoring of body chemistries, has raised more than $45 million in Series C financing. The backers were VMS Investment Group, Tasly Pharmaceutical Group, Maxim Integrated Ventures, 3E Bioventures Capital and Atinum Investment.
14 August 2018•1 min read
